| 000 | 00993 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515103941.0 | ||
| 264 | 0 | _c20080131 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1544-3450 | ||
| 024 | 7 |
_a10.1331/JAPhA.2008.08502 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrabenstein, John D | |
| 245 | 0 | 0 |
_aAdvantages of standardizing vaccine and antibody nomenclature. _h[electronic resource] |
| 260 |
_bJournal of the American Pharmacists Association : JAPhA _c |
||
| 300 |
_a105-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies _xclassification |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedication Errors _xprevention & control |
| 650 | 0 | 4 | _aTerminology as Topic |
| 650 | 0 | 4 |
_aVaccines _xclassification |
| 773 | 0 |
_tJournal of the American Pharmacists Association : JAPhA _gvol. 48 _gno. 1 _gp. 105-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1331/JAPhA.2008.08502 _zAvailable from publisher's website |
| 999 |
_c17700638 _d17700638 |
||